Dorsey Wright & Associates’s Patterson-UTI PTEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-103,791
Closed -$2.52M 161
2017
Q1
$2.52M Buy
103,791
+69,178
+200% +$1.87M 0.86% 32
2016
Q4
$932K Buy
+34,613
New +$855K 0.4% 97
2014
Q4
Sell
-13,954
Closed -$454K 140
2014
Q3
$454K Sell
13,954
-127
-0.9% -$4.31K 0.06% 82
2014
Q2
$531K Buy
+14,081
New +$462K 0.06% 86

Other funds holding PTEN

Dorsey Wright & Associates's PTEN Position: Q2 2017 in Review

Dorsey Wright & Associates sold out of Patterson-UTI (PTEN) in Q2 2017, closing a stake of 103,791 shares — an estimated $2.52M sold.

Dorsey Wright & Associates first reported a position in PTEN in Q2 2014 and held it in 4 quarters. The position peaked at $2.52M in Q1 2017. 310 funds tracked by Wall St. Rank hold PTEN as of Q2 2017.

  • Dorsey Wright & Associates reported no remaining Patterson-UTI position as of Q2 2017 after selling out during the quarter.
  • Dorsey Wright & Associates sold 103,791 Patterson-UTI shares in Q2 2017, an estimated $2.52M.
  • Dorsey Wright & Associates first reported a position in Patterson-UTI in Q2 2014 and held it in 4 quarters.
  • Dorsey Wright & Associates's Patterson-UTI position peaked at $2.52M in Q1 2017.
  • 310 funds tracked by Wall St. Rank held Patterson-UTI as of Q2 2017.

Based on Dorsey Wright & Associates's 13F filing for Q2 2017, filed 10 Aug 2017.